Study: Trauma patients treated with rFVIIa require fewer transfusions

03/26/2009 | Doctor's Guide

German researchers demonstrated that early treatment of trauma patients using recombinant factor VIIa reduced transfusions of red blood cells and fresh frozen plasma. The study, however, did not show that rFVIIa also reduces mortality. Further studies are needed to pinpoint the potential benefits of rFVIIa to selected groups of patients, the lead researcher said.

View Full Article in:

Doctor's Guide

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ